Osteopenia in Eugonadal Men with Acquired Immune Deficiency Syndrome Wasting Syndrome1-Reference-Cited by-同舟云学术

Osteopenia in Eugonadal Men with Acquired Immune Deficiency Syndrome Wasting Syndrome1

Published:2001-05-01 Issue:5 Volume:86 Page:2020-2026
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Fairfield Wesley P.¹,Finkelstein Joel S.²,Klibanski Anne¹,Grinspoon Steven K.¹

Affiliation:

1. Neuroendocrine Unit (W.F., A.K., S.G.), Boston, Massachusetts 02114

2. Endocrine Unit (J.F.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/86/5/2020/9164172/jcem2020.pdf

Reference27 articles.

1. HIV disease and the endocrine system.;Grinspoon;N Engl J Med,1992

2. Treatments for wasting in patients with the acquired immunodeficiency syndrome.;Corcoran;N Engl J Med,1999

3. Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy.;Aukrust;J Clin Endocrinol Metab,1999

4. Symptomatic osteoporosis in two young HIV-positive African women.;Stephens;AIDS,1999

5. Bone mineral density in patients with human immunodeficiency virus infection.;Paton;Calcif Tissue Int,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of exercise training on bone health in adults living with HIV: a systematic review with meta-analysis;AIDS Care;2024-03-19

2. Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss;Frontiers in Pharmacology;2020-03-27

3. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years;Osteoporosis International;2019-03-26